Contact this trialFirst, we need to learn more about you.
Protein Kinase Inhibitor
Epcoritamab Combo for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 2
Winston-Salem, North Carolina
This trial is assessing the safety and tolerability of epcoritamab in combination with anti-neoplastic agents in adult participants with Non-Hodgkin lymphoma (NHL). Approximately 132 adult participants with NHL will be enrolled in 100 sites globally.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.